alnylam
An associate scientist-II position in the protein sciences team focused on protein production and conjugation efforts. The role involves working in a lab to support research and development of therapeutic proteins and antibodies, utilizing various analytical techniques and collaborating across multidisciplinary teams.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2002
Alnylam is a biopharmaceutical company that has pioneered RNA interference (RNAi) therapeutics, an innovative class of medicines that treats diseases by silencing the genes that cause or contribute to them. The company develops RNAi-based medicines targeting both rare and prevalent diseases across multiple therapeutic areas, with approved products and a robust investigational pipeline. Driven by science and inspired by patients, Alnylam is committed to delivering transformational medicines that address diseases at their genetic source.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for alnylam.
19% above the average for this role
Protein Expression and Purification Scientist
MSD
Scientist I, Biologics Production
PharmaEssentia
Associate Scientist II, Protein Sciences
Alnylam Pharmaceuticals
Scientist, Product Biochemistry
Regeneron Pharmaceuticals
Protein Reagents Scientist
Regeneron Pharmaceuticals
Associate Scientist - Therapeutic Protein
Regeneron Pharmaceuticals